Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden · Delayed Price · Currency is SEK 10.10
+0.17 (1.71%)
Sep 2, 2026, 5:29 PM CET
Xspray Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -159.44 | -171.44 | -285.52 | -179.67 | -131.67 | -96.7 |
Depreciation & Amortization | 5.2 | 5.58 | 8.55 | 9.19 | 9.53 | 8.87 |
Loss (Gain) From Sale of Assets | - | - | 22.77 | 0.01 | - | 0.1 |
Other Operating Activities | 0.28 | 3.13 | 27.25 | -1.23 | 15.53 | 31.75 |
Change in Accounts Receivable | -7.9 | -0.4 | 1.34 | -4.11 | -2.94 | -5.71 |
Change in Inventory | 15.56 | -1.96 | -6.03 | -35.23 | - | - |
Change in Other Net Operating Assets | -4.05 | -28.07 | 9.28 | 7.76 | -0.63 | 10.09 |
Operating Cash Flow | -150.35 | -193.16 | -222.37 | -203.28 | -110.18 | -51.61 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | -4.38 | -2.69 | -24.47 | -1.31 |
Sale (Purchase) of Intangibles | -19.73 | -29.19 | -37.76 | -49.86 | -103.82 | -94.65 |
Other Investing Activities | - | - | - | -13.33 | -7.06 | -9.85 |
Investing Cash Flow | -19.73 | -29.19 | -42.14 | -65.88 | -135.35 | -105.82 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 120 | 96 | 45 | - | - |
Long-Term Debt Repaid | - | -105.14 | -4.89 | -1.65 | -2.13 | -2.15 |
Net Debt Issued (Repaid) | 14.73 | 14.86 | 91.11 | 43.35 | -2.13 | -2.15 |
Issuance of Common Stock | 274.62 | 161.13 | 235.4 | 297.92 | 100 | 99.88 |
Other Financing Activities | -13.24 | -7.7 | -20.4 | -25.68 | -4.06 | 5.99 |
Financing Cash Flow | 276.11 | 168.29 | 306.11 | 315.59 | 93.81 | 103.71 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.06 | -0.44 | 0.33 | -0.31 | - | - |
Net Cash Flow | 106.1 | -54.49 | 41.93 | 46.14 | -151.72 | -53.72 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -150.35 | -193.16 | -226.75 | -205.97 | -134.65 | -52.92 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -6096.71% | -7833.05% | - | - | - | - |
Free Cash Flow Per Share | -3.60 | -5.02 | -6.84 | -7.75 | -6.39 | -2.75 |
Levered Free Cash Flow | -122.39 | -164.64 | -177.16 | -188.45 | -203.39 | -142.37 |
Unlevered Free Cash Flow | -108.14 | -154.11 | -175.95 | -188.02 | -203.38 | -142.37 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 22.64 | 13.62 | 2.91 | 1.17 | 0.15 | 0 |
Change in Working Capital | 3.61 | -30.43 | 4.59 | -31.58 | -3.58 | 4.38 |